WallStreetZenWallStreetZen

NASDAQ: ATOS
Atossa Therapeutics Inc Stock Ownership - Who owns Atossa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atossa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
H. Lawrence RemmelDirector2025-03-2610,000$0.70
$7.00kBuy

1 of 1

ATOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATOS insiders and whales buy or sell their stock.

ATOS Shareholders

What type of owners hold Atossa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.56%9,759,549$7.76MInstitution
Steven C. Quay7.49%9,679,716$7.70MInsider
Shuchih Chen7.04%9,095,173$7.23MInsider
Vanguard Group Inc5.12%6,618,969$5.26MInstitution
Geode Capital Management LLC2.18%2,814,177$2.24MInstitution
State Street Corp1.36%1,755,369$1.40MInstitution
Renaissance Technologies LLC1.21%1,557,632$1.24MInstitution
Ubs Group Ag0.87%1,124,703$894.14kInstitution
Northern Trust Corp0.79%1,025,724$815.45kInstitution
Morgan Stanley0.35%452,196$359.50kInstitution

1 of 3

ATOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATOS23.17%14.77%Net BuyingNet Buying
TNXP48.86%51.14%Net SellingNet Selling
CCCC78.11%21.89%Net SellingNet Selling
TVRD3.49%96.51%Net SellingNet Selling
LCTX41.22%58.78%Net BuyingNet Selling
View Top Biotech Stocks

Atossa Therapeutics Stock Ownership FAQ

Who owns Atossa Therapeutics?

Atossa Therapeutics (NASDAQ: ATOS) is owned by 23.17% institutional shareholders, 14.77% Atossa Therapeutics insiders, and 62.06% retail investors. Steven C. Quay is the largest individual Atossa Therapeutics shareholder, owning 9.68M shares representing 7.49% of the company. Steven C. Quay's Atossa Therapeutics shares are currently valued at $8.69M.

If you're new to stock investing, here's how to buy Atossa Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.